AliveCor has received an additional FDA 510(k) clearance, this time for an algorithm that allows its smartphone ECG to detect atrial fibrillation -- an abnormal heart rhythm that isn't always ...

January 31, 2006-- Hybrid therapy, consisting of right atrial overdrive pacing and antiarrhythmic drugs (AADs), reduces symptomatic atrial fibrillation (AF) in patients who have severely symptomatic ...

PARIS — Early radiofrequency ablation was superior to antiarrhythmic drugs to delay the progression to persistent atrial fibrillation among patients with drug-refractory paroxysmal AF, according to ...

August 26, 2003 — The addition of a rate-adaptive atrial pacing algorithm to dual-chambered rate responsive (DDDR) pacemakers is safe and effective in reducing symptomatic atrial fibrillation (AF) ...

Antiarrhythmic drugs can cause new, potentially deadly heart arrhythmias. Amiodarone is effective but can cause serious side effects and requires careful monitoring. Multaq cannot be used in people ...

Atrial fibrillation (AF) is a growing clinical problem associated with increased morbidity and mortality Currently available antiarrhythmic drugs (AADs) can be highly effective in acute cardioversion ...

Fitbit launched a large-scale study to test the efficacy of its technology in identifying irregular heart rhythms, which could indicate potential cases of atrial fibrillation. Fitbit said it plans to ...

Patients with atrial fibrillation or AFib experience chaotic electrical signals in the upper chamber of their heart (atria), which cause an irregular or quivering heartbeat (arrhythmia) that can lead ...

PFA was noninferior to cryoablation for first recurrence of atrial tachyarrhythmia in patients with paroxysmal atrial fibrillation. Tissue-selective energy delivery and short application times offer ...